יחס מהיר seraprognostics.com (SERA)

As reflected in the chart, the asset value of Sera Prognostics (SERA), which specializes in prenatal diagnostics, is 1.94. The business's defense is based on patents and complex clinical trials that create a barrier to entry. High margins are driven by scalable software and unique blood analysis algorithms. However, risks include pressure from large networks and the slow pace of integration into insurance systems.

The quick ratio measures a company's ability to settle short-term obligations using cash and accounts receivable, completely excluding illiquid inventories. This metric serves as a rigorous stress-testing tool for an issuer's solvency under crisis scenarios. By analyzing the quick ratio, an investor assesses the efficiency of working capital management. For Sera Prognostics (SERA), this is critical when financing the transition to eco-friendly packaging and expensive biodegradable materials.